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To the Editor: Rickettsia felis, which belongs to the 
spotted fever group of rickettsiae, causes febrile illness in 
humans. The main vector of this bacterium is the cat flea 
(Ctenocephalides felis). Since publication of reports of R. 
felis as a putative pathogen of humans in the United States 
in 1994, R. felis infection in humans worldwide has been 
increasingly described, especially in the Americas, Europe, 
Africa, and eastern Asia (1,2). R. felis infection is common 
among febrile patients (≈15%) in tropical Africa (3) and 
among apparently healthy persons in eastern coastal prov-
inces of China (4). However, little is known about preva-
lence of R. felis infection of humans in southern Asia, al-
though 3 serologically diagnosed cases in Sri Lanka have 
been described (5) and R. felis has been detected in rodent 
fleas in Afghanistan (6). Hence, we conducted a cross-sec-
tional study in Bangladesh to explore the presence of rickett-
sial pathogens among patients with fever of unknown origin.
Study participants were 150 patients at Mymensingh 
Medical College (MMC) hospital in Mymensingh, north-
central Bangladesh, from July 2012 through January 2014, 
and 30 healthy control participants from the staff at the 
same college. Selected patients met the following criteria: 
1) fever (axillary temperature >37.5°C) for >15 days that 
did not respond to common antimicrobial drug therapy; 2) 
any additional clinical features including headache, rash, 
lymphadenopathy, myalgia, and eschars on skin; and 3) ti-
ter according to the Weil-Felix test (antibodies against any 
of 3 Proteus antigens) of >1:80. Patients with evident cause 
of fever (e.g., malaria diagnosed by blood smear or immu-
nochromatography) were excluded from the study. This 
research was approved by the college institutional review 
board, and informed consent was obtained from patients 
(or guardians) and healthy controls before their entry into 
the study.
Venous blood samples were aseptically collected 
from the patients, and DNA was extracted by conventional 
method by using proteinase K and sodium dodecyl sulfate. 
Nested PCR selective for the 17-kDa antigen gene was 
used to screen for rickettsiae according to the method de-
scribed previously (7); ≈100 ng of DNA in a 50-mL reac-
tion mixture was used. For each PCR, a negative control 
(water) was included and utmost care was taken to avoid 
contamination. Among the 150 samples tested, results were 
positive with a 232-bp amplified product for 69 (46%) and 
negative for all controls. 
PCR products from 20 samples were randomly select-
ed for sequence analysis. All nucleotide sequences from 
 Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 21, No. 8, August 2015 1483
LETTERS
the 17-kDa antigen gene (186-bp) were identical to that of 
reference strain R. felis URRWXCa12 (GenBank acces-
sion no. CP000053). Among all 17-kDa–positive samples, 
positivity was further confirmed by PCR detection of the R. 
felis 16S rRNA gene and gltA in 95% and 75% of samples, 
respectively. Partial 16S rRNA gene sequences (305-bp) 
from 12 samples were 100% or 99% (10 and 2 samples, 
respectively) identical to that of R. felis URRWXCa12. The 
complete open reading frames of ompA (1773-bp), partial 
ompB (413-bp), and gltA (611-bp) sequences determined 
for 3, 3, and 5 samples, respectively, were also identical 
to those of R. felis URRWXCa12. The 5 gene sequences 
were determined for samples from 3 patients (2-year-old 
girl, 8-year-old boy, 17-year-old boy). The 5 gene se-
quences from the 2-year-old girl (strain Ric-MMC7) and 
2 partial sequences of 16S rRNA (Ric-MMC71 and Ric-
MMC133) were deposited in GenBank under accession 
nos. KP318088–KP318094.
According to PCR, the positivity rate for the R. fe-
lis 17-kDa antigen gene was higher among male (54%, 
40/74) than among female (38%, 29/76) patients and 
higher among patients in young and old age groups (0–15 
years, 57%; 45–60 years, 62%) than among patients in 
other age groups (15–30 years, 41%; 30–45 years, 44%). 
During the study period, rates of R. felis positivity were 
highest during the late rainy season of 2012 (September 
[59%] and October [52%]) and lowest (0%) from Decem-
ber 2012 through April 2013 (Figure). The rate was sig-
nificantly higher among farmers (76%, 13/17) than among 
persons of other occupations (e.g., housewives, teachers, 
students) (42%, 56/133); p = 0.016. Among the 69 rick-
ettsiae-positive patients, headache and myalgia were re-
ported by 29 (42%) and 17 (25%), respectively, whereas 
rash was detected in only 2 (3%) patients, both of whom 
were female.
This study demonstrated R. felis infection in patients in 
Bangladesh with unidentified febrile illness. The high preva-
lence (46%) of R. felis infection suggests that this infection is 
endemic to the north-central area of this country and might 
be associated with contact between humans of low socioeco-
nomic status and the large number of stray cats and dogs. In 
contrast, the number of genetically confirmed cases of R. felis 
infection in humans reported to date in China, Taiwan, Thai-
land, and Laos have been very few (1,2,4,8–10), although 
widespread presence of this bacterium in cat fleas has been 
documented. For further confirmation of spread of this in-
fectious disease, the prevalence of R. felis infections among 
humans, vectors, and reservoirs in other areas in Bangladesh 
and in other countries in southern Asia should be investigated. 
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To the Editor: Doxycycline is an effective antimalar-
ial prophylactic drug when administered as a monotherapy 
1 day before, daily during, and for 4 weeks after travel 
to an area where malaria is endemic (1). Doxycycline is 
currently a recommended chemoprophylactic regimen for 
travelers visiting areas where malaria is endemic and has 
a high prevalence of chloroquine or multidrug resistance 
(2). The World Health Organization also recommends 
doxycycline in combination with quinine or artesunate as 
the second-line treatment for uncomplicated Plasmodium 
falciparum malaria (3).
Prophylactic and clinical failures of doxycycline against 
P. falciparum have been associated with both inadequate 
doses (4) and poor patient compliance (5). However, resis-
tance can also explain failures of prophylaxis. Cycline re-
sistance in Plasmodium spp. has been documented as a con-
sequence of selective drug pressure in a P. berghei murine 
malaria model (6). The administration of increasing doses 
of minocycline to mice infected with 1 × 107 parasites for 86 
successive passages over 600 days made it possible to obtain 
a resistant P. berghei strain with a median drug inhibitory 
concentration (IC50) of 600 mg/kg/d, which is 6-fold higher 
than that of the susceptible starting strain (100 mg/kg/d) (6). 
A Bayesian mixture modeling approach identified 3 differ-
ent phenotypes (low, medium, and high doxycycline IC50 
phenotypic groups) among P. falciparum clinical isolates 
(7,8). Using 90 isolates from 14 countries, we demonstrated 
that increases in copy numbers of P. falciparum metabolite 
drug transporter gene (Pfmdt, PFE0825w) and P. falciparum 
GTPase TetQ gene (PfTetQ, PFL1710c) are associated with 
reduced susceptibility to doxycycline (9); this association 
was later confirmed (7). In addition, isolates with PfTetQ 
KYNNNN motif repeats are associated with in vitro reduced 
susceptibility to doxycycline and with a significantly higher 
probability of having an IC50 above the doxycycline resis-
tance threshold of 35 mM (9,10).
We report a case of documented malaria prophylac-
tic failure with doxycycline in a 26-year-old soldier from 
France who was infected during a 6-week peacekeeping 
mission in the Central African Republic in 2014. According 
to his colleagues and the collective prophylaxis intake, the 
patient had been compliant with doxycycline prophylaxis. 
On admission to a hospital in Bangui, Central African Re-
public, the patient had fever (temperature 40°C), alteration 
of consciousness, and hypotension. The diagnosis of severe 
P. falciparum malaria was made on the basis of a rapid diag-
nostic test confirmed by a blood smear test (parasitemia 8% 
on day 0). Intravenous artesunate was immediately started, 
in accordance with World Health Organization recommen-
dations (3). The patient’s clinical condition worsened, and 
kidney failure developed. Twenty-four hours later (day 1), 
he was transported by airplane to Bégin Military Teach-
ing Hospital (Saint-Mandé, France). On admission, he had 
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